首页 › 基金 › PSP Research LLC › SUPN

PSP Research LLC 对 SUPN 的持仓历史

SUPERNUS PHARMACEUTICALS · 医疗保健

PSP Research LLC 在 Q3 2026 的 13F 申报中披露持有 SUPN(SUPERNUS PHARMACEUTICALS)6,000 股,市值约 US$258K,约占其申报组合的 0.18%,在其申报持仓中市值排名第 15 位。 PSP Research LLC 最近 4 个申报季度中有 4 个季度披露了 SUPN 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)6.00K 股
申报持仓市值$258.24K
组合权重0.18%
首次申报Q4 2025
最近变动持有
更新于2026-10-21

最后更新: 2026-10-21 · 来源: SEC EDGAR Form 13F-HR

PSP Research LLC 对 SUPN 的持仓演变

PSP Research LLC 于 Q4 2025 首次披露 SUPN 持仓:10,758 股(约 US$535K)。 在 4 次申报中,PSP Research LLC 0 次增持、1 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 6,000 股、市值约 US$258K。 持仓曾出现大幅变动:Q1 2026 减持约 44% (随后一个季度股价下跌 10%)。

逐季持仓明细

季度股数金额变化
Q4 2025 10.76K $534.67K 新进
Q1 2026 6.00K $310.14K 减持
Q2 2026 6.00K $279.06K 持有
Q3 2026 6.00K $258.24K 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SUPN 与 13F 数据

SUPN(SUPERNUS PHARMACEUTICALS)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 SUPN,申报仓位最大的包括:MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SUPN 的基金

查看 SUPN 的全部基金持有人 →

常见问题

How long has PSP Research LLC held SUPN?

PSP Research LLC has disclosed SUPN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in SUPN?

As of Q3 2026, PSP Research LLC holds 6.00K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $258.24K, representing 0.18% of its reported portfolio and ranking #15.

Has PSP Research LLC been buying or selling SUPN?

In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in SUPN.

Which other funds hold SUPN?

Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.